Both fall under WADA Code S0, the non-approved-substances category
1c) of acid-ethanol extracts of rat gastric and ileal mucosa identified proglucagon, GLP-1, and GLP-2 fragments consistent with PC1/3 cleavage sites after trypsin, Lys-C, chymotrypsin, and Glu-C digestion
Although the drug has a long-standing history of use to treat Type 2 diabetes and its symptoms, semaglutide is now being used to address weight loss in non-diabetic patients and showing dramatic effects
In sum: Uncertain risks plus an unclear benefit equals a trade-off thats just not worth it
Owner's reply Thank you for your kind words about our Registered Nurse, Jessica
These bitesize tweaks are the same levers we lean on to ease LDL and bloodpressure numbers, proving meds and smart eating can work handinhand